Injective Protocol (INJ) traded at $7.84 on October 13, 2026, a decline of 2.09% over the prior 24 hours. The dip tempered but did not erase a broader rally that has defined the token's recent trajectory.
Over the past seven days, INJ held a gain of 1.89%, suggesting the short-term pullback has been relatively contained. The more striking figure comes from the 30-day window, where the token has surged 35.72%, reflecting a sustained period of buying pressure over the past month.
Injective Protocol's market capitalization stood at $0.76 billion at the time of reporting. That figure places the asset within the mid-tier range of the broader cryptocurrency market.
The daily decline positions INJ in line with broader softness occasionally seen across crypto markets, though the token's 30-day performance continues to stand out as one of the stronger moves among tracked digital assets in recent weeks.
